Literature DB >> 35904618

A systematic review of prognosis predictive role of radiomics in pancreatic cancer: heterogeneity markers or statistical tricks?

Yuhan Gao1, Sihang Cheng1, Liang Zhu1, Qin Wang1, Wenyi Deng1, Zhaoyong Sun1, Shitian Wang1, Huadan Xue2.   

Abstract

OBJECTIVES: We aimed to systematically evaluate the prognostic prediction accuracy of radiomics features extracted from pre-treatment imaging in patients with pancreatic ductal adenocarcinoma (PDAC).
METHODS: Radiomics literature on overall survival (OS) prediction of PDAC were all included in this systematic review. A further meta-analysis was performed on the effect size of first-order entropy. Methodological quality and risk of bias of the included studies were assessed by the radiomics quality score (RQS) and prediction model risk of bias assessment tool (PROBAST).
RESULTS: Twenty-three studies were finally identified in this review. Two (8.7%) studies compared prognosis prediction ability between radiomics model and TNM staging model by C-index, and both showed a better performance of the radiomics. Twenty-one (91.3%) studies reported significant predictive values of radiomics features. Nine (39.1%) studies were included in the meta-analysis, and it showed a significant correlation between first-order entropy and OS (HR 1.66, 95%CI 1.18-2.34). RQS assessment revealed validation was only performed in 5 (21.7%) studies on internal datasets and 2 (8.7%) studies on external datasets. PROBAST showed that 22 (95.7%) studies have a high risk of bias in participants because of the retrospective study design.
CONCLUSION: First-order entropy was significantly associated with OS and might improve the accuracy of PDAC prognosis prediction. Existing studies were poorly validated, and it should be noted in future studies. Modification of PROBAST for radiomics studies is necessary since the strict requirements of prospective study design may not be applicable to the demand for a large sample size in the model construction stage. KEY POINTS: • Radiomics based on the primary lesion holds great potential for prognosis prediction. First-order entropy was significantly associated with the overall survival of PDAC and might improve the accuracy of current PDAC prognosis prediction. • We strongly recommend that at least an internal validation should be conducted in any radiomics study. Attention should be paid to the complex relationships between radiomics features. • Due to the close relationship between radiomics and big data, the strict requirement of prospective study design in PROABST may not be appropriate for radiomics studies. A balance between study types and sample sizes for radiomics studies needs to be found in the model construction stage.
© 2022. The Author(s), under exclusive licence to European Society of Radiology.

Entities:  

Keywords:  Pancreatic neoplasms; Prognosis; Systematic review

Year:  2022        PMID: 35904618     DOI: 10.1007/s00330-022-08922-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   7.034


  42 in total

1.  Cancer Statistics, 2021.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2021-01-12       Impact factor: 508.702

Review 2.  Tumor Heterogeneity in Pancreatic Adenocarcinoma.

Authors:  Jerome Cros; Jerome Raffenne; Anne Couvelard; Nicolas Poté
Journal:  Pathobiology       Date:  2017-08-05       Impact factor: 4.342

Review 3.  Intra-tumour heterogeneity: a looking glass for cancer?

Authors:  Andriy Marusyk; Vanessa Almendro; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2012-04-19       Impact factor: 60.716

Review 4.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

5.  Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma.

Authors:  Si Shi; Jie Hua; Chen Liang; Qingcai Meng; Dingkong Liang; Jin Xu; Quanxing Ni; Xianjun Yu
Journal:  Ann Surg       Date:  2019-05       Impact factor: 12.969

6.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

7.  Original study: The rescue staging for pancreatic ductal adenocarcinoma with inadequate examined lymph nodes.

Authors:  Ningzhen Fu; Weishen Wang; Dongfeng Cheng; Jiancheng Wang; Zhiwei Xu; Xiaxing Deng; Chenghong Peng; Hao Chen; Baiyong Shen
Journal:  Pancreatology       Date:  2021-02-18       Impact factor: 3.996

8.  Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS).

Authors:  Johanna A M G Tol; Dirk J Gouma; Claudio Bassi; Christos Dervenis; Marco Montorsi; Mustapha Adham; Ake Andrén-Sandberg; Horacio J Asbun; Maximilian Bockhorn; Markus W Büchler; Kevin C Conlon; Laureano Fernández-Cruz; Abe Fingerhut; Helmut Friess; Werner Hartwig; Jakob R Izbicki; Keith D Lillemoe; Miroslav N Milicevic; John P Neoptolemos; Shailesh V Shrikhande; Charles M Vollmer; Charles J Yeo; Richard M Charnley
Journal:  Surgery       Date:  2014-07-22       Impact factor: 3.982

9.  Survival improvement in patients with pancreatic cancer by decade: a period analysis of the SEER database, 1981-2010.

Authors:  Huanhuan Sun; Haiqing Ma; Guobin Hong; Hongliu Sun; Jin Wang
Journal:  Sci Rep       Date:  2014-10-23       Impact factor: 4.379

10.  Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study.

Authors:  Anas M Saad; Tarek Turk; Muneer J Al-Husseini; Omar Abdel-Rahman
Journal:  BMC Cancer       Date:  2018-06-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.